Mackey Ashley M 4/A
4/A · Sanara MedTech Inc. · Filed May 5, 2026
Research Summary
AI-generated summary of this filing
Sanara MedTech (SMTI) Controller Ashley Mackey Receives Award
What Happened Ashley M. Mackey, Controller of Sanara MedTech Inc. (SMTI), was granted 2,804 shares of restricted common stock on March 22, 2026. The award was reported at $0.00 per share (no cash paid). The restricted shares vest in three equal annual installments on March 22 of 2027, 2028 and 2029, subject to continued employment.
Key Details
- Transaction date: March 22, 2026 — Grant/award (code A).
- Shares granted: 2,804 restricted shares; reported acquisition price: $0.00.
- Shares owned after transaction: 4,967 shares (amendment corrects prior report).
- Filing status: This is an amended Form 4 filed May 5, 2026, restating the March 23, 2026 original to reduce previously reported beneficial ownership (originally misstated as 5,067 shares).
- Vesting: One-third vests on each of Mar 22, 2027; Mar 22, 2028; Mar 22, 2029, contingent on continued employment.
Context This transaction is an equity award under Sanara MedTech’s 2024 Omnibus Long-Term Incentive Plan, not an open-market buy or sale. Awards like restricted stock are typical compensation and do not by themselves indicate a personal purchase or sale intent. The amendment corrects the insider’s reported holdings; the original Form 4 was filed promptly (Mar 23, 2026), and the May 5, 2026 filing simply restates and corrects the record.
Insider Transaction Report
- Award
Common Stock
[F1][F2]2026-03-22+2,804→ 4,967 total
Footnotes (2)
- [F1]Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Issuer") to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest in three equal installments, with one-third of the shares vesting on March 22, 2027, 2028 and 2029, respectively, provided that the reporting person is employed by the Issuer through each such date.
- [F2]The original Form 4, filed on March 23, 2026, is being amended and restated in its entirety to reduce the number of shares of common stock of the Issuer reported as being beneficially owned by the reporting person. The original Form 4 mistakenly indicated that the reporting person held 5,067 shares of common stock, when in fact, as reported in this amendment, the reporting person held 4,967 shares of common stock following the reported transaction.